Basics Ventyx Biosciences, Inc. IPO Date: October 21, 2021 Sector: Healthcare Industry: Biotech Market Cap: $268.12M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 3.87% Avg Daily Range (30 D): $0.12 | 3.85% Avg Daily Range (90 D): $0.11 | 4.15% Institutional Daily Volume Avg Daily Volume: 1.06M Avg Daily Volume (30 D): 1.68M Avg Daily Volume (90 D): 1.19M Trade Size Avg Trade Size (Sh.): 129 Avg Trade Size (Sh.) (30 D): 157 Avg Trade Size (Sh.) (90 D): 161 Institutional Trades Total Inst.Trades: 1,120 Avg Inst. Trade: $1.83M Avg Inst. Trade (30 D): $.96M Avg Inst. Trade (90 D): $1.33M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.18M Avg Closing Trade (30 D): $.95M Avg Closing Trade (90 D): $1.54M Avg Closing Volume: 135.84K     News Sep 6, 2024 @ 12:00 PM Ventyx Biosciences Announces Initiation of Dosing ... Source: Ventyx Biosciences, Inc. May 16, 2024 @ 8:05 PM Ventyx Biosciences to Participate in Three Upcomin... Source: Ventyx Biosciences, Inc. May 2, 2024 @ 8:05 PM Ventyx Biosciences to Report First Quarter 2024 Fi... Source: Ventyx Biosciences, Inc. Apr 30, 2024 @ 4:00 PM What Makes Ventyx Biosciences (VTYX) a New Buy Sto... Source: Zacks Equity Research Apr 5, 2024 @ 12:01 PM Kura Sushi Posts Upbeat Sales, Joins Caribou Biosc... Source: Avi Kapoor Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.67 $-.38 $-.39 Diluted EPS $-1.67 $-.38 $-.39 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -119.03M $ -26.99M $ -27.44M Operating Income / Loss $ -130.4M $ -29.33M $ -30.1M Cost of Revenue $ $ $ Net Cash Flow $ -8.94M $ 4.68M $ M PE Ratio